No Evidence That WHO-recommended Treatment For Insecticide Poisoning Improves Survival

Date:

July 5, 2009

Source:

Public Library of Science

Summary:

A new study finds no evidence to suggest that a controversial antidote recommended by the World Health Organization (WHO) to treat patients poisoned with highly toxic insecticides improves their chance of survival. The results may even add weight to existing concerns about pralidoxime, the treatment recommended by the WHO, by suggesting that it could be harmful in patients who have deliberately poisoned themselves with insecticides.

Share:

Total shares:

FULL STORY

A new study finds no evidence to suggest that a controversial antidote recommended by the World Health Organisation (WHO) to treat patients poisoned with highly toxic insecticides improves their chance of survival. The results may even add weight to existing concerns about pralidoxime, the treatment recommended by the WHO, by suggesting that it could be harmful in patients who have deliberately poisoned themselves with insecticides.

Poisoning with organophosphorus pesticides - toxic chemicals commonly used in agriculture in developing countries is a global public health problem causing an estimated 200,000 deaths a year. Deliberate self-poisoning with pesticides is a common method of suicide in some countries- in Sri Lanka, more than 50% of fatal suicide attempts are a result of pesticide poisoning. Michael Eddleston, from the University of Edinburgh, and colleagues conducted a clinical trial to study the effects of WHO-recommended pralidoxime treatment in patients who had been admitted to two hospitals in Sri Lanka for insecticide self-poisoning.

If ingested by humans the pesticides disrupt the communication between the brain and body, inhibiting the activity of a neurotransmitter called acetylcholine, which plays a crucial role in the central nervous system and the control of breathing. To treat organophosphate poisoning, the WHO recommends that in addition to atropine, an antidote that is known to reverse some but not all of the effects of the poisoning, a regimen of pralidoxime should be used to reactivate acetylcholine activity. As the authors of this study mention, few randomized clinical trials have been conducted into its use, meaning that there is a lack of evidence for its effectiveness, in particular relating to dosage.

The researchers enrolled 235 patients at two Sri Lankan hospitals who had self-poisoned with organophosphate insecticides, determining how much, and which, pesticide each patient had been exposed to, and randomly allocating them to receive either the WHO-recommended regimen of pralidoxime or a salt water placebo. However, the trial was stopped early and did not reach its intended study size owing to discussions surrounding the results of another trial of pralidoxime therapy, carried out in India at the same time which led to a fall-off in recruitment of patients. In the Sri Lankan trial, published in PLoS Medicine, more patients in the pralidoxime arm died than in the placebo arm, despite the fact that pralidoxime was shown to aid acetylcholine activity. Whilst the difference in mortality between arms was not statistically significant, it is suggestive of a higher mortality rate resulting from pralidoxime treatment.

Acknowledging the difficult situation that clinicians now face when deciding whether or not to administer pralidoxime to patients poisoned with organophosphorus pesticides, the authors conclude that there is no consistent clinical evidence for the use of pralidoxime in patients who have self-poisoned with organophosphorus pesticides. They argue that further trials are needed to explore the risks and benefits of oximes and dosing regimens.

ME is a Wellcome Trust Career Development Fellow. This work was funded by grant 063560 from the Wellcome Trust's Tropical Interest Group to ME. The South Asian Clinical Toxicology Research Collaboration is funded by a Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant 071669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Public Library of Science. (2009, July 5). No Evidence That WHO-recommended Treatment For Insecticide Poisoning Improves Survival. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2009/06/090629211805.htm

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

Apr. 14, 2014  Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. "Results from our study demonstrate that ... read more

May 15, 2013  Neonicotinoid insecticides have adverse effects not only on bees but also on freshwater invertebrates. Exposure to low but constant concentrations of these substances – which are highly soluble in ... read more

Sep. 25, 2012  The most cost-effective treatment for cryptococcal meningitis (a serious infection of the brain membranes, usually in people with AIDS or other immune system deficiencies) is different to that ... read more

Mar. 16, 2011  Quinine should no longer be the drug of choice for treating severe malaria, according to an updated systematic review. It is now evident that the antimalarial drug artesunate, which is derived from ... read more